GE HealthCare Technologies Inc. $GEHC Shares Sold by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. reduced its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 49.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,998 shares of the company’s stock after selling 2,880 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in GE HealthCare Technologies were worth $222,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of the business. Nvwm LLC boosted its stake in shares of GE HealthCare Technologies by 5,483.1% in the second quarter. Nvwm LLC now owns 14,237 shares of the company’s stock worth $1,055,000 after buying an additional 13,982 shares during the last quarter. Malaga Cove Capital LLC boosted its position in GE HealthCare Technologies by 204.7% in the 2nd quarter. Malaga Cove Capital LLC now owns 9,299 shares of the company’s stock worth $689,000 after purchasing an additional 6,247 shares in the last quarter. Modera Wealth Management LLC grew its stake in shares of GE HealthCare Technologies by 3.5% during the 2nd quarter. Modera Wealth Management LLC now owns 4,500 shares of the company’s stock worth $333,000 after purchasing an additional 152 shares during the period. Soltis Investment Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 6.5% during the 2nd quarter. Soltis Investment Advisors LLC now owns 2,977 shares of the company’s stock valued at $220,000 after purchasing an additional 181 shares in the last quarter. Finally, Golden State Wealth Management LLC lifted its stake in shares of GE HealthCare Technologies by 7.4% in the 2nd quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock valued at $158,000 after purchasing an additional 148 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 0.4%

NASDAQ:GEHC opened at $74.65 on Thursday. The firm has a market cap of $34.00 billion, a P/E ratio of 15.41, a PEG ratio of 2.76 and a beta of 1.13. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The stock’s 50 day simple moving average is $75.20 and its 200-day simple moving average is $73.65.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same period in the previous year, the business posted $1.14 earnings per share. The business’s revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.89%.

Analysts Set New Price Targets

GEHC has been the subject of several research analyst reports. Morgan Stanley upped their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 30th. BTIG Research set a $87.00 price objective on GE HealthCare Technologies in a research note on Wednesday, October 29th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Citigroup lowered GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $86.10.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.